These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3663906

  • 1. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV, Kalishevskaia TM.
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of the development of acquired antithrombin III deficiency in the experimental nephrotic syndromes.
    Bashkov GV, Kalishevskaya TM, Strukova SM.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Sep; 115(3):324-8. PubMed ID: 2465224
    [Abstract] [Full Text] [Related]

  • 3. [Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
    Bashkov GV.
    Biull Eksp Biol Med; 1990 Aug; 110(8):133-6. PubMed ID: 2291954
    [Abstract] [Full Text] [Related]

  • 4. Substitution of antithrombin III.
    Breddin HK, Kirchmaier CM.
    Wien Klin Wochenschr; 1984 Dec 21; 96(24):875-9. PubMed ID: 6528616
    [Abstract] [Full Text] [Related]

  • 5. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P.
    Thromb Haemost; 1981 Oct 21; 46(3):623-5. PubMed ID: 6171906
    [Abstract] [Full Text] [Related]

  • 6. [Acquired antithrombin III deficiency].
    Müller G.
    Z Gesamte Inn Med; 1992 Feb 21; 47(2):74-7. PubMed ID: 1585693
    [Abstract] [Full Text] [Related]

  • 7. [Thromboembolism. The clinical significance of antithrombin III].
    Schramm W.
    Internist (Berl); 1984 Feb 21; 25(2):88-92. PubMed ID: 6368458
    [No Abstract] [Full Text] [Related]

  • 8. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND, Paule P, Toohey J, Hung E, Alikhani S, Darwish R, Pahl MV.
    Arch Intern Med; 1984 Sep 21; 144(9):1802-3. PubMed ID: 6477000
    [Abstract] [Full Text] [Related]

  • 9. [Significance of antithrombin III in kidney diseases].
    Schrader J, Köstering H, Scheler F.
    Behring Inst Mitt; 1986 Feb 21; (79):216-30. PubMed ID: 3718408
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):239-44. PubMed ID: 18541230
    [Abstract] [Full Text] [Related]

  • 11. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH, Gouault-Heilmann M, Levent M, Bernard D, Ruszniewski P, Lagrue G.
    Ann Med Interne (Paris); 1983 Jul 28; 134(8):713-6. PubMed ID: 6666909
    [Abstract] [Full Text] [Related]

  • 12. [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].
    Oikawa T, Muramatsu Y, Akashi S, Usui N.
    Nihon Jinzo Gakkai Shi; 1993 Oct 28; 35(10):1163-9. PubMed ID: 8264106
    [Abstract] [Full Text] [Related]

  • 13. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A.
    Nephrologie; 1992 Oct 28; 13(4):151-7. PubMed ID: 1407255
    [Abstract] [Full Text] [Related]

  • 14. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V, Triolo L, De Martini D, Ferrelli R, Mori R, Leone G.
    J Lab Clin Med; 1987 May 28; 109(5):550-5. PubMed ID: 3572202
    [Abstract] [Full Text] [Related]

  • 15. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G, Kouame C.
    Nephrologie; 1994 May 28; 15(6):387-9. PubMed ID: 7862227
    [Abstract] [Full Text] [Related]

  • 16. [Antithrombin III deficiency in the nephrotic syndrome. Threatened thrombosis treated with fresh plasma].
    Frifelt JJ, Jørgensen KA, Rosleff F.
    Ugeskr Laeger; 1984 Jul 09; 146(28):2092-3. PubMed ID: 6515799
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G, Hellstern P, Köhler M, Scheffler P, Wenzel E.
    Behring Inst Mitt; 1986 Feb 09; (79):200-15. PubMed ID: 3718407
    [Abstract] [Full Text] [Related]

  • 18. Antithrombin III deficiency and thromboembolism.
    Thaler E, Lechner K.
    Clin Haematol; 1981 Jun 09; 10(2):369-90. PubMed ID: 7032781
    [No Abstract] [Full Text] [Related]

  • 19. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L, Miniello VL, Francioso G, Aceto G, DiBitonto G, Penza R.
    Boll Soc Ital Biol Sper; 1982 Sep 15; 58(17):1093. PubMed ID: 7138678
    [Abstract] [Full Text] [Related]

  • 20. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R, Jaubert F, Leon M, Bellon B, Aiach M, Josso F, Lepelletier O, Beguin S, Monnet JP.
    Thromb Haemost; 1983 Feb 28; 49(1):13-7. PubMed ID: 6601862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.